STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the Visian Implantable Collamer Lens (ICL), and new Visian ICL with CentraFLOW technology utilizing the KS-AquaPORT, were …
Category: News
First European Human Embryonic Stem Cell Trial Gets Go Ahead
The European authorities have given the go ahead for trials to treat patients with Stargardt’s Macular Dystrophy (SMD) using retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs). If successful, the trial may pave the way…
AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1.5 million from the Foundation Fighting Blindness to fu…
OPKO Announces Sale of Ophthalmic Instrumentation Business
MIAMI–(BUSINESS WIRE)–OPKO Health, Inc. (NYSE: OPK) has agreed to sell its ophthalmic instrumentation business to OPTOS, Inc., a subsidiary of Optos plc, a leading and rapidly growing medical technology company engaged in the design, development, man…
AGTC Receives Grant from the Foundation Fighting Blindness for Pre-Clinical Study of Gene Therapy for Eye Disease
GAINESVILLE, Fla.–(BUSINESS WIRE)–AGTC receives significant grant funding from the Foundation Fighting Blindness to develop treatment for genetic eye disease, XLRS, causing blindness in young boys.
Canaloplasty an Option in Open-Angle Glaucoma
Canaloplasty works just as well as trabeculectomy in reducing intraocular pressure (IOP) in patients with open-angle glaucoma, according to a comparative case series in Ophthalmology.
IRIDEX licenses rights to Ocunetics’ intellectual property
IRIDEX Corporation today announced that it has exclusively licensed the rights to all of the intellectual property of Ocunetics, Inc., a privately held company based in Alamo, California. Ocunetics develops procedure-enabling medical devices that are …
Canaloplasty an Option in Open-Angle Glaucoma
Canaloplasty works just as well as trabeculectomy in reducing intraocular pressure (IOP) in patients with open-angle glaucoma, according to a comparative case series in Ophthalmology. Reuters Health Information
Social Media Primer for Healthcare Professionals
Popular social media sites can benefit healthcare professionals, if used appropriately. Find out how. Medscape Public Health
ERWW PR forms Health Buzz Group
Euro RSCG Worldwide PR (ERWW PR) announces the formation of its Health Buzz Group, a global division created in response to growing client interest in big, splashy “wows” from small budgets in quick time frames using traditional and social media to…
Innovative Solutions For Restoring Vision
Max Planck Society (Max-Planck-Gesellschaft), Germany’s leading basic research organization, has announced that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify a…
Advanced Bionics Announces FDA Approval For U.S. Market Re-Entry Of The HiRes 90K Cochlear Implant
Advanced Bionics (AB), the only U.S.-based manufacturer of cochlear implants and a subsidiary of Switzerland-based Sonova, announced today the approval of the FDA for immediate market re-entry of the HiRes 90K cochlear implant in the United States…
Venus Williams withdraws from US Open due to Sjogren syndrome
Sjogren syndrome was in the news recently when tennis player, Venus Williams, was forced to withdraw form the US Open tennis tournament due to symptoms from the disease.
Proton Irradiation for Choroidal Melanomas Near Optic Nerve
For patients with melanoma near the optic nerve, proton beam radiotherapy offers benefits in terms of eye conservation and low recurrence, but with a tradeoff in visual acuity, according to a new study. Reuters Health Information
New collaboration reinforces Sanofi’s translational discovery platform for retinal diseases
The Max Planck Society (Max-Planck-Gesellschaft), Germany’s leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to iden…
CHAM experts available to discuss variety of back-to-school issues
Experts from The Children’s Hospital at Montefiore (CHAM) are available for interviews on a variety of back-to-school issues.
Common Treatments Can Lead To Antibiotic Resistance
Overexposure to antibiotics has long been a concern in the medical community most specifically the development of antibiotic resistant infections as a result of repeated use…
Eyelid Lipid Plaques Predict CV Disease (CME/CE)
(MedPage Today) — The presence of the lipid-containing yellow plaques known as xanthelasmata on the eyelids is an independent predictor of cardiovascular disease, a large prospective study found.
EHR Voice Recognition: An End to the ‘No Eye Contact’ Problem?
Physicians often complain that when using an EHR, they’re so busy typing that it’s hard to make good eye contact with patients. New voice recognition software holds promise, but is it there yet? Medscape Business of Medicine
Orphan Drug Status for Corneal Cross-Linking in Keratoconus
Corneal cross-linking is the first medical therapy available in the US to slow disease progress. Medscape Medical News